Anaesthesia
Conditions
Interventions
Sponsors
Faculty of Medicine Suez Canal University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: -Adult age: 18 – 60 years old. - Sex: (both: male &female) - ASA (American Society of Anesthesiologists) status I & II: [ASA I: A normal healthy patient (Fit, nonobese (BMI under 30), a nonsmoking patient with good exercise tolerance). ASA II: A patient with mild systemic disease (Patient with no functional limitations and a well-controlled disease (e.g., treated hypertension, obesity with BMI under 35, frequent social drinker, or cigarette smoker)] -Diagnosed by dermatology specialist to be having herpes zoster virus disease. -Onset of pain and vesicles starting within a week.
Exclusion criteria
Exclusion criteria: -Coagulation abnormalities: platelet count1.5 -Patients with mental or psychiatric disease that would interfere with perception and assessment of pain. -Allergy to Local Anesthetic. - Serum creatinine more than 1.5 mg /dl -Diabetes (to exclude other cause of neuropathic pain). -Patients coming > 3months after rash healing.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare between the efficacy of ESPB versus ICNB for management of acute herpetic neuralgia using visual analogue scale (VAS) score. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Testing efficacy of both modalities measured by total consumption of analgesics. 2. Testing efficacy of both modalities in prevention of development of postherpetic neuralgia. 3. Improvement of quality of life of patients and reduction of morbidities resulting from acute herpetic neuralgia. | — |
Countries
Egypt
Contacts
Public ContactEman Teema
Lecturer of Anesthesia and Intensive Care Faculty of Medicine Suez Canal University
Outcome results
None listed